1. Journal of Microbiology, Immunology and Infection
Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan 
Ching-Tsai Lin, Wen-Nan Huang, Chia-Wei Hsieh, Yi-Ming Chen, Der-Yuan Chen, Tsu-Yi Hsieh, Yi-Hsing Chen 
Journal of Microbiology, Immunology and Infection 
DOI: /j.jmii
Copyright © Terms and Conditions

2. Figure 1 Patient flow in 114 RA patients treated with tocilizumab.
Journal of Microbiology, Immunology and Infection DOI: ( /j.jmii )
Copyright © Terms and Conditions

3. Figure 2
Disease activity before and after tocilizumab treatment. (A) DAS28-ESR (B) ACR 20, 50 and 70 response.
Journal of Microbiology, Immunology and Infection DOI: ( /j.jmii )
Copyright © Terms and Conditions

4. Figure 3
Change of lipid profile and GPT before and after tocilizumab treatment. (A) Total cholesterol (B) LDL-C (C) Triglyceride (D) the ratio of T.C./HDL-C (E) HDL-C (F) GPT. * denotes p < 0.05. NS: non-statistical significance.
Journal of Microbiology, Immunology and Infection DOI: ( /j.jmii )
Copyright © Terms and Conditions

5. Figure 4
Outcome of patients with comorbidity of TB or hepatitis B viral infection. (A) Distribution of patients with old TB or latent TB infection with and without isoniazid (INAH) prophylaxis. Data was presented as (patient number, percentage). None of the 23 patients developed active TB infection during the follow-up period. (B) HBV viral loads before and after TCZ under pre-emptive antiviral therapy.
Journal of Microbiology, Immunology and Infection DOI: ( /j.jmii )
Copyright © Terms and Conditions